From the beginning of the covid-19 pandemic, we have already tested approx. 2,500 patients as part of various research projects.

Despite the ongoing Covid-19 pandemic at the BRG facility, we are still active and with ongoing projects. We maintain constant contact with our patients who are open to participation in new research. In order to maintain appropriate prophylaxis and safety of the conducted projects we perform according to the highest standards, using instructions and procedures of the Ministry of Health, Sanitary-epidemiological station, WHO (World Health Organization) and EMA (European Medicines Agency).

We have already tested approximately 2,500 patients as part of various research projects. The safety of patients is supervised by qualified nurses, laboratory technicians, pharmacists and coordinators as well as recognized medical experts with many years of experience and knowledge. This confirm that our site is effective and efficient and able to provide rapid study start-up for trials research of various therapies even in challenging environment.

Go back

News

Phase IIa diabetes study termination

We have succesfully completed phase II study for patients suffered from diabetes type II.

Read more …

Rivaroxaban bioequivalence studies

Our site has completed 5 bioequivalence studies with Rivaroxaban. The studies were conducted in our 1st phase unit in Kajetany.

Read more …

Clinical study with cladribine completed

We have succesfully completed phase I study for female patients suffering from multiple sclerosis.

Read more …

31st Great Final of WOŚP

31st Great Final of Wielka Orkiestra Świątecznej Pomocy.

Lets play till the end of the world and one day longer!

Read more …

Merry Christmas

We wish you Merry Christmas and Happy New Year!

Read more …

About Us | Services | Our Site | Partners | Smoking Risk Study | Contact Us

Early Phase Clinical Trials

2024 © Bio Research Group. All rights reserved.

 

scroll to top ▲